ZINPLAVA (Bezlotoxumab) Drug Insight and Market Forecasts, 2019-2032: Developed by Merck Sharp & Dohme, A Human Monoclonal Antibody that Binds to C
January 24, 2024 08:17 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ZINPLAVA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed picture...
Bacterial Therapeutics Beyond Antibiotics, 2023 Research Study - Antibodies, Probiotics, Bacteriophages, and Antimicrobial Peptides Currently Undergoing Clinical Trials
June 12, 2023 06:58 ET
|
Research and Markets
Dublin, June 12, 2023 (GLOBE NEWSWIRE) -- The "Bacterial Therapeutics Beyond Antibiotics" report has been added to ResearchAndMarkets.com's offering. As bacteria grow resistant to conventional...